01 September, 2017
The ratio dived, as 80 investment professionals increased or started new stock positions, while 78 sold and decreased their positions in Clovis Oncology Inc. The company has market cap of $36.06 billion. Compared to individual investors, institutional investors trade in large blocks, 10,000 or more shares per transaction. It has outperformed by 20.71% the S&P500. Nine Masts Capital Ltd acquired 342,672 shares as Au Optronics Corp (AUO)'s stock rose 3.46%. The Blue Jay Capital Management Llc holds 298,982 shares with $13.28 million value, down from 335,000 last quarter. The SI to Clovis Oncology Incorporated's float is 22.56%.
The stock increased 4.57% or $3.23 on August 30, reaching $73.87. About 411,991 shares traded. Karyopharm Therapeutics Inc (KPTI) has risen 21.19% since August 30, 2016 and is uptrending. It has outperformed by 39.52% the S&P500.
Pura Vida Investments Llc decreased Amarin Corp Plc (NASDAQ:AMRN) stake by 225,000 shares to 250,000 valued at $770,000 in 2016Q4. It also reduced General Electric Co (NYSE:GE) stake by 11,700 shares and now owns 29,300 shares. Sivik Lc has 0.32% invested in Clovis Oncology Inc (NASDAQ:CLVS). Bank of America Corporation dropped their target price on shares of Clovis Oncology from $103.00 to $75.00 and set a "buy" rating for the company in a research report on Tuesday, June 20th. The firm earned "Buy" rating on Tuesday, July 18 by Credit Suisse. Chardan Capital Markets upgraded the shares of CLVS in report on Monday, June 19 to "Neutral" rating. They issued a "market perform" rating on the stock. The stock has "Buy" rating by SunTrust on Wednesday, August 24. As per Friday, April 29, the company rating was maintained by Goldman Sachs. The firm has "Buy" rating by RBC Capital Markets given on Sunday, August 13. The company was upgraded on Thursday, January 26 by PiperJaffray. As per Wednesday, August 24, the company rating was maintained by SunTrust. For CLVS, the company now has $491.79 Million of cash on the books.
Investors sentiment increased to 1.24 in 2016 Q4. Its up 0.14, from 0.89 in 2016Q3. At present, 9 analysts recommended Holding these shares while 2 recommended sell, according to FactSet data. 60 funds opened positions while 161 raised stakes. (NASDAQ:AMZN). Loeb Prns Corporation holds 0.09% or 350 shares. Columbia Wanger Asset Mgmt Limited Liability Corporation holds 189,958 shares or 0.12% of its portfolio. The California-based Redmile Group Llc has invested 6.2% in the stock. Bourgeon Capital Management Limited Liability reported 0.15% stake. Proshare Advisors Limited Liability Corporation, a Maryland-based fund reported 30,597 shares. Jpmorgan Chase & Company accumulated 170,388 shares. The stock declined 2.25% or $1.66 reaching $72.05 per share. ValuEngine lowered shares of Clovis Oncology from a "hold" rating to a "sell" rating in a research note on Friday, May 19th. Therefore 72% are positive. Amazon.com had 188 analyst reports since July 21, 2015 according to SRatingsIntel. JP Morgan upgraded the shares of CLVS in report on Wednesday, May 17 to "Overweight" rating. The stock has "Neutral" rating by Mizuho on Monday, November 16. The firm has "Neutral" rating by Piper Jaffray given on Monday, April 4. On Monday, May 15 IVERS-READ GILLIAN C sold $142,170 worth of Clovis Oncology Inc (NASDAQ:CLVS) or 3,000 shares. Wells Fargo And Mn invested 0% of its portfolio in Clovis Oncology Inc (NASDAQ:CLVS). Wellington Management Group LLP now owns 1,331,669 shares of the biopharmaceutical company's stock valued at $84,788,000 after buying an additional 1,318,669 shares in the last quarter. As per Monday, May 9, the company rating was maintained by WallachBeth Capital.
Since March 1, 2017, it had 0 insider purchases, and 13 insider sales for $960.72 million activity. Ghost Tree Capital, LLC now owns 301,000 shares with a value of $28,183,000. Redmile Gru Ltd Company owns 1.62M shares or 6.2% of their U.S. portfolio. (NASDAQ:AMZN). The California-based Mechanics Bankshares Trust Department has invested 0.24% in Amazon.com, Inc. Collegium Pharmaceutical Inc was raised too.
Investors sentiment decreased to 1.81 in 2016 Q4. Its down 0.34, from 1.7 in 2016Q3. It is negative, as 30 investors sold Clovis Oncology Inc shares while 48 reduced holdings. Alliancebernstein L.P. raised its position in Clovis Oncology by 1,538.0% in the first quarter. Following the completion of the sale, the insider now owns 200,583 shares in the company, valued at approximately $12,400,041.06. Raymond James Tru Na holds 0.25% in Amazon.com, Inc. Huff W R Asset Limited Liability De owns 38,600 shares. Blackrock Gp Ltd holds 20,918 shares. Tiaa Cref Investment Mgmt Ltd Liability Com stated it has 273,070 shares. Deutsche Savings Bank Ag reported 0% stake. Everyone seems to have their own opinion of this stock. 712,237 are owned by D E Shaw And. On average, equities analysts predict that Clovis Oncology, Inc. will post ($7.53) earnings per share for the current year. Ghost Tree Cap Ltd Liability stated it has 220,000 shares.
